FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robin DiFrancesco

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Robin DiFrancesco; P Pande; S L Rosenkranz; S Siminski; C R Taylor; K Tooley; G D Morse
Clinical Pharmacology Quality Assurance for HIV and Related Infectious Diseases Research.
Xinyan Zhang; Hongyu Jiang; Gene Morse; Camlin Tierney; Mary Albrecht; Lisa M Demeter; Robin DiFrancesco; Carrie Dykes; David W Haas
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.
Kathleen M Tornatore; Gregory E Wilding; Kris Attwood; Robin DiFrancesco; Vanessa Gray; Aijaz C Gundroo; Patcharaporn Sudchada; Rocco Venuto
Race and drug formulation influence on mycophenolic acid pharmacokinetics in stable renal transplant recipients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robin DiFrancesco (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Robin DiFrancesco; P Pande; S L Rosenkranz; S Siminski; C R Taylor; K Tooley; G D Morse
Clinical Pharmacology Quality Assurance for HIV and Related Infectious Diseases Research.
Clinical pharmacology and therapeutics 2013;93(6):479-82.
2013: Xinyan Zhang; Hongyu Jiang; Gene Morse; Camlin Tierney; Mary Albrecht; Lisa M Demeter; Robin DiFrancesco; Carrie Dykes; David W Haas
Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146.
Therapeutic drug monitoring 2013;35(2):209-16.
2013: Kathleen M Tornatore; Gregory E Wilding; Kris Attwood; Robin DiFrancesco; Vanessa Gray; Aijaz C Gundroo; Patcharaporn Sudchada; Rocco Venuto
Race and drug formulation influence on mycophenolic acid pharmacokinetics in stable renal transplant recipients.
Journal of clinical pharmacology 2013;53(3):285-93.
2013: Robin DiFrancesco; Getrude Maduke; Rutva Patel; Charlene R Taylor; Gene D Morse
Antiretroviral bioanalysis methods of tissues and body biofluids.
Bioanalysis 2013;5(3):351-68.
2011: Kathleen M Tornatore; Gregory E Wilding; Julia Zack; Kris Attwood; Ryan T Danison; Robin DiFrancesco; Kiran Dole; Alan Forrest; Aijaz C Gundroo; Nicolae Leca; Patcharaporn Sudchada; Rocco Venuto
Mycophenolic acid pharmacokinetics during maintenance immunosuppression in African American and Caucasian renal transplant recipients.
Journal of clinical pharmacology 2011;51(8):1213-22.
2011: Qing Ma; Charles S Venuto; Barry S Zingman; Robin DiFrancesco; Margaret A Fischl; Alan Forrest; Barbara Gripshover; Amneris E Luque; Gene D Morse
Therapeutic drug monitoring of protease inhibitors and efavirenz in HIV-infected individuals with active substance-related disorders.
Therapeutic drug monitoring 2011;33(3):309-14.
2008: Lisa M Demeter; A Lisa Mukherjee; Robin DiFrancesco; Hongyu Jiang; Robert DiCenzo; Barbara Bastow; Alex R Rinehart; Gene D Morse; Mary Albrecht
The design and implementation of A5146, a prospective trial assessing the utility of therapeutic drug monitoring using an inhibitory quotient in antiretroviral-experienced HIV-infected patients.
HIV clinical trials 2008;9(1):61-72.
2007: Elinore F McCance-Katz; David E Moody; Gene D Morse; Qing Ma; Robin DiFrancesco; Gerald Friedland; Patricia Pade; Petrie M Rainey
Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.
Drug and alcohol dependence 2007;91(2-3):269-78.
2007: Niamh Higgins; Barry S Zingman; Judianne C Slish; Richard C Reichman; Margaret A Fischl; Barbara Gripshover; Kelly Tooley; Naomi Boston; Alan Forrest; Daniel A Brazeau; Linda M Catanzaro; Robin DiFrancesco; Francesco Lliguicota; Qing Ma; Gene D Morse
Factors associated with altered pharmacokinetics in substance users and non-substance users receiving lopinavir and atazanavir.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2007;16(6):488-94.
2007: Robin DiFrancesco; Valerie A Frerichs; Julie Donnelly; Colleen Hagler; Jill Hochreiter; Kathleen M Tornatore
Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;859(1):42-51.
2007: Judianne C Slish; Qing Ma; Barry S Zingman; Richard C Reichman; Margaret A Fischl; Barbara Gripshover; Alan Forrest; Daniel A Brazeau; Naomi S Boston; Linda M Catanzaro; Robin DiFrancesco; Gene D Morse
Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring.
Therapeutic drug monitoring 2007;29(5):560-5.
2007: Robin DiFrancesco; Robert DiCenzo; Glorimar Vicente; Julie Donnelly; Troy M Martin; Luis A Colon; Giovanni Schifito; Gene D Morse
Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry.
Journal of pharmaceutical and biomedical analysis 2007;44(5):1139-46.
2007: Robin DiFrancesco; Jennifer J Griggs; Julie Donnelly; Robert DiCenzo
Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;852(1-2):545-53.
2007: Robin DiFrancesco; Margaret A Fischl; Julie Donnelly; Barry S Zingman; Elinore F McCance-Katz; David E Moody; Richard C Reichman; Barbara Gripshover; Gene D Morse
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
Journal of pharmaceutical and biomedical analysis 2007;44(1):188-95.
2007: Olanrewaju Okusanya; Alan Forrest; Robin DiFrancesco; Sanela Bilic; Susan L Rosenkranz; Michael F Para; Elizabeth Adams; Kevin E Yarasheski; Richard C Reichman; Gene D Morse
Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.
Antimicrobial agents and chemotherapy 2007;51(5):1822-6.
2007: Qing Ma; Daniel A Brazeau; Barry S Zingman; Richard C Reichman; Margaret A Fischl; Barbara Gripshover; Charles S Venuto; Judianne C Slish; Robin DiFrancesco; Alan Forrest; Gene D Morse
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.
Pharmacogenomics 2007;8(3):227-35.
2007: Kim Keil; Jill Hochreitter; Robin DiFrancesco; Barry S Zingman; Richard C Reichman; Margaret A Fischl; Barbara Gripshover; Gene D Morse
Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
Therapeutic drug monitoring 2007;29(1):103-9.
2006: Kim Keil; Robin DiFrancesco; Gene D Morse
Determination of tipranavir in human plasma by reverse phase liquid chromatography with UV detection using photodiode array.
Therapeutic drug monitoring 2006;28(4):512-6.
2006: Robin DiFrancesco; Susan L Rosenkranz; Jean Craft; Gene D Morse
Tutorial reduces protocol deviations in multicenter ACTG trials with pharmacology endpoints.
HIV clinical trials 2006;7(4):203-9.
2006: Diane T Holland; Robin DiFrancesco; James D Connor; Gene D Morse
Quality assurance program for pharmacokinetic assay of antiretrovirals: ACTG proficiency testing for pediatric and adult pharmacology support laboratories, 2003 to 2004: a requirement for therapeutic drug monitoring.
Therapeutic drug monitoring 2006;28(3):367-74.
2006: Troy M Martin; Gene D Morse; Jaclynn Kurpewski; Robin DiFrancesco; Angela M Caliendo; Timothy P Flanigan; Karen T Tashima
Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir.
AIDS (London, England) 2006;20(7):1085-7.
2006: Desiree L Tomilo; Patrick F Smith; Abayomi B Ogundele; Robin DiFrancesco; Charles S Berenson; Ellana Eberhardt; Edward Bednarczyk; Gene D Morse
Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers.
Pharmacotherapy 2006;26(3):341-6.
2005: Gene D Morse; Susan L Rosenkranz; Michael F Para; Yoninah Segal; Robin DiFrancesco; Elizabeth Adams; Barbara Brizz; Kevin E Yarasheski; Richard C Reichman
Amprenavir and efavirenz pharmacokinetics before and after the addition of nelfinavir, indinavir, ritonavir, or saquinavir in seronegative individuals.
Antimicrobial agents and chemotherapy 2005;49(8):3373-81.
2005: Patrick F Smith; Robert DiCenzo; Alan Forrest; Mark J Shelton; Gerald Friedland; Michael F Para; Richard B Pollard; Margaret A Fischl; Robin DiFrancesco; Gene D Morse
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.
Clinical pharmacokinetics 2005;44(1):99-109.
2004: Diane T Holland; Robin DiFrancesco; Judith Stone; Fayez M Hamzeh; James D Connor; Gene D Morse
Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories.
Antimicrobial agents and chemotherapy 2004;48(3):824-31.
2004: Mark J Shelton; Denise Cloen; Robin DiFrancesco; Charles S Berenson; Andrew Esch; Pascal J de Caprariis; Branka Palic; Jane L Schur; Christopher J L Buggé; Anders Ljungqvist; Orlando Espinosa; Ross G Hewitt
The effects of once-daily saquinavir/minidose ritonavir on the pharmacokinetics of methadone.
Journal of clinical pharmacology 2004;44(3):293-304.
2003: Mark J Shelton; Angela A Giovanniello; Denise Cloen; Charles S Berenson; Kim Keil; Robin DiFrancesco; Ross G Hewitt
Effects of didanosine formulations on the pharmacokinetics of amprenavir.
Pharmacotherapy 2003;23(7):835-42.
2003: Kim Keil; Valerie A Frerichs; Robin DiFrancesco; Gene D Morse
Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma.
Therapeutic drug monitoring 2003;25(3):340-6.
2003: Valerie A Frerichs; Robin DiFrancesco; Gene D Morse
Determination of protease inhibitors using liquid chromatography-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;787(2):393-403.
2002: Charles E Frost; Lawrence J Gugino; Ross Hewitt; J Hu; Elizabeth Ingalls; John Adams; Stephen Cousins; Robin DiFrancesco; Abdel-Hameed I Mohammed Ebid; Mark Shelton; Gene D Morse
Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected Women.
Clinical drug investigation 2002;22(2):125-34.
2001: Kathleen M Tornatore; K W Garey; N Saigal; K Reed; B Murray; E Ingalls; Robin DiFrancesco; Alan Forrest; Gene D Morse; Rocco Venuto
Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection.
Clinical transplantation 2001;15(5):297-308.
2001: Mark J Shelton; H E Wynn; Ross G Hewitt; Robin DiFrancesco
Effects of grapefruit juice on pharmacokinetic exposure to indinavir in HIV-positive subjects.
Journal of clinical pharmacology 2001;41(4):435-42.
1998: JM Adams; Mark J Shelton; Ross G Hewitt; M DeRemer; Robin DiFrancesco; T H Grasela; Gene D Morse
Zalcitabine population pharmacokinetics: application of radioimmunoassay.
Antimicrobial agents and chemotherapy 1998;42(2):409-13.